Dynamic graphical user interface for prescription rights application for electronic devices

Abstract

1. Name of this design product: Dynamic graphical user interface for electronic equipment. 2. Purpose of the product of this design: An electronic device used to run programs and display a graphical user interface for human-computer interaction. 3. The key design points of this appearance design product lie in the interface content and dynamic change process of the graphical interface. 4. The picture or photo that best illustrates the key points of the design: main view. 5. The design for which protection is sought includes color. 6. Purpose of the graphical user interface: The interface of this design is used to fill in the operational process of applying for prescription rights. 7. Human-computer interaction methods of the graphical user interface: The main view is the main interface for human-computer interaction; Interface Change State Figure 1 is entered by clicking the drop-down box next to "Select Application Method" in the main view; Interface Change State Figure 2 is entered by clicking the drop-down box "Multiple Applications for One Drug" in the interface change state figure 1; Interface Change State Figure 3 is entered by clicking the "+" key in the lower right corner of interface change state figure 2; Interface Change State Figure 4 is entered by clicking the magnifying glass icon in the "Drug Name (Generic Name)" table corresponding to sequence number 1 in interface change state figure 3; Interface Change State Figure 5 is entered by clicking the row containing "Sintilimab Injection" in interface change state figure 4; Interface Change State Figure 6 is entered by clicking the "+" key in the lower right corner of interface change state figure 5; Interface Change State Figure 7 is entered by clicking the magnifying glass icon in the "Drug Name (Generic Name)" table corresponding to sequence number 2 in interface change state figure 6; Interface Change State Figure 8 is entered by clicking the row containing "Sintilimab Injection" in interface change state figure 7.

Images